J.a. United Exports Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: J.a. United Exports Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $134.8K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

J.a. United Exports Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $134.8K Trade | TransData Nexus

J.a. United Exports Private Limited

Indian Pharmaceutical Exporter · Advanced Oncology Specialist · $134.8K Total Trade · DGFT Verified

J.a. United Exports Private Limited is an Indian pharmaceutical exporter with a total trade value of $134.8K across 2 products in 1 therapeutic categories. Based on 26 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Rituximab ($122.3K), Vinorelbine ($12.6K), .

J.a. United Exports Private Limited — Export Portfolio & Destination Treemap

J.a. United Exports Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is J.a. United Exports Private Limited? — Company Overview & Market Position

J.A. United Exports Private Limited is a privately held pharmaceutical trading and distribution company based in Navi Mumbai, Maharashtra, India. Established on January 20, 2011, the company operates under the Corporate Identification Number (CIN) U51101MH2011PTC212575. Its registered office is located at B-506/507, City Mall, Mayuresh Trade Centre, Sector 19, Vashi Turbhe Road, Vashi, Navi Mumbai, Maharashtra, 400705.

The company specializes in the sourcing and marketing of medicinal goods, including pharmaceuticals, bulk drugs, chemicals, medical devices, surgical goods, and other hospital products. J.A. United Exports Pvt Ltd has developed a network of key business centers strategically located worldwide to enhance its participation in major global markets. The company's overriding goal is to link suppliers and customers quickly and efficiently.

As of the latest available financial data, the company reported a total export value of $135,000 USD across 26 shipments, focusing on two products within the Advanced Oncology therapeutic category. The top two exported products are Rituximab, with a value of $122,000 USD (0.6% market share), and Vinorelbine, valued at $13,000 USD (0.4% market share). The company's portfolio is highly concentrated, with these two products accounting for 100% of its exports.

What Does J.a. United Exports Private Limited Export? — Product Portfolio Analysis

Product Portfolio — Top 2 by Export Value

J.a. United Exports Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Rituximab	Advanced Oncology	$122.3K	20	0.6%	8
2	Vinorelbine	Advanced Oncology	$12.6K	6	0.4%	11

J.a. United Exports Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $134.8K. The top category is Advanced Oncology (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

J.a. United Exports Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

J.A. United Exports Private Limited operates as a trading and distribution entity and does not own or operate manufacturing facilities. The company focuses on sourcing and marketing medicinal goods, including pharmaceuticals, bulk drugs, chemicals, medical devices, surgical goods, and other hospital products. Its business model involves leveraging a network of key business centers strategically located worldwide to enhance its participation in major global markets.

3Key Leadership

The leadership team of J.A. United Exports Private Limited comprises two directors:

Maurice Doojappa Rosario: Serving as a director since the company's inception on January 20, 2011.

Monthu Doojappa Rosario: Also serving as a director since January 20, 2011.

The company's leadership is committed to facilitating the sourcing and marketing of medicinal goods through a wide distribution network, aiming to link suppliers and customers efficiently.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does J.a. United Exports Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

J.A. United Exports Private Limited's export activities are primarily focused on the Advanced Oncology therapeutic category, with products such as Rituximab and Vinorelbine. The company's export data indicates a total export value of $135,000 USD across 26 shipments, with these two products accounting for 100% of its exports. However, specific details regarding regulatory filings, approvals, and market access status in the United States, European Union, United Kingdom, Australia, and Japan are not publicly available. The company's website does not provide detailed information on its regulatory standing in these markets.

2Emerging Markets

J.A. United Exports Private Limited's export data indicates a total export value of $135,000 USD across 26 shipments, focusing on two products within the Advanced Oncology therapeutic category. However, specific details regarding the company's presence and market penetration in Africa, Latin America, and Southeast Asia are not publicly available. The company's website does not provide detailed information on its activities in these regions.

3Geographic Strategy

J.a. United Exports Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

J.A. United Exports Private Limited operates as a trading and distribution entity and does not own or operate manufacturing facilities. Therefore, the company does not have FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. The company's focus is on sourcing and marketing medicinal goods through a wide distribution network.

2WHO & EU GMP

J.A. United Exports Private Limited operates as a trading and distribution entity and does not own or operate manufacturing facilities. Therefore, the company does not hold WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status. The company's focus is on sourcing and marketing medicinal goods through a wide distribution network.

3CDSCO & Indian Regulatory

J.A. United Exports Private Limited operates as a trading and distribution entity and does not own or operate manufacturing facilities. Therefore, the company does not hold manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), state drug controller approvals, or export No Objection Certificates (NOCs). The company's focus is on sourcing and marketing medicinal goods through a wide distribution network.

J.a. United Exports Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

J.A. United Exports Private Limited operates in the pharmaceutical trading and distribution sector, focusing on sourcing and marketing medicinal goods through a wide distribution network. The company's export data indicates a total export value of $135,000 USD across 26 shipments, with a portfolio concentrated on two products within the Advanced Oncology therapeutic category. Specific details regarding the company's competitors in overlapping categories, market share comparisons, and head-to-head analyses are not publicly available. The company's website does not provide detailed information on its competitive landscape.

2Key Differentiators

J.A. United Exports Private Limited's key differentiators include its specialization in the sourcing and marketing of medicinal goods, including pharmaceuticals, bulk drugs, chemicals, medical devices, surgical goods, and other hospital products. The company has developed a network of key business centers strategically located worldwide to enhance its participation in major global markets. Its overriding goal is to link suppliers and customers quickly and efficiently.

3Strategic Position

Buyer Due Diligence Brief — Evaluating J.a. United Exports Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

J.A. United Exports Private Limited operates as a trading and distribution entity, focusing on sourcing and marketing medicinal goods through a wide distribution network. The company's export data indicates a total export value of $135,000 USD across 26 shipments, with a portfolio concentrated on two products within the Advanced Oncology therapeutic category. Specific details regarding the company's overall track record, export volume and consistency, and reliability indicators are not publicly available. The company's website does not provide detailed information on its supplier assessment.

2Certifications to Verify

As J.A. United Exports Private Limited operates as a trading and distribution entity and does not own or operate manufacturing facilities, the company does not hold certifications such as FDA approvals, WHO-GMP, EU GMP, or ISO. Therefore, importers do not need to verify these certifications when considering business with the company. The company's focus is on sourcing and marketing medicinal goods through a wide distribution network.

3Due Diligence Checklist

Frequently Asked Questions — J.a. United Exports Private Limited

How many pharmaceutical products does J.a. United Exports Private Limited export from India?

J.a. United Exports Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Rituximab ($122.3K), Vinorelbine ($12.6K). Total export value is $134.8K.

What is J.a. United Exports Private Limited's total pharmaceutical export value?

J.a. United Exports Private Limited's total pharmaceutical export value is $134.8K, based on 26 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does J.a. United Exports Private Limited cover?

J.a. United Exports Private Limited exports across 1 therapeutic categories. The largest are Advanced Oncology (100.0%, 2 products).

Get Full J.a. United Exports Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.